Hims & Hers Health HIMS
NYSE HIMS
$31.86 +0.77 (+2.48%)
At close: Aug 20, 2026 · 4:00 PM EDT

Hims & Hers Health (HIMS) Income towards Parent Company (2019 - 2026)

Hims & Hers Health (HIMS) posted Income towards Parent Company of -$92.1 million for Q1 2026, down 547.14% sequentially from $20.6 million in Q4 2025, and down 286.15% YoY from $49.5 million in Q1 2025.

Hims & Hers Health (HIMS) Income towards Parent Company (2019 - 2026) Analysis & Trends

Hims & Hers Health has reported Income towards Parent Company for 8 years, with the latest figure at -$92.1 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 286.15% year-over-year to -$92.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.2 million (down 108.05% YoY) and the FY2025 annual result came in at $128.4 million, up 1.85% from the prior year.
  • Income towards Parent Company retreated to -$92.1 million in Q1 2026 per HIMS's latest filing, from $20.6 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $75.6 million in Q3 2024 and troughed at -$92.1 million in Q1 2026.
  • A 5-year average of $4.3 million and a median of $1.2 million in 2023 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2024 and 2026: Income towards Parent Company surged 1990.36% in 2024, then plunged 286.15% in 2026.
  • Over 5 years, Income towards Parent Company stood at -$10.9 million in 2022, then surged by 111.41% to $1.2 million in 2023, then soared by 1990.36% to $26.0 million in 2024, then retreated by 20.84% to $20.6 million in 2025, then sank by 547.14% to -$92.1 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$92.1 million, $20.6 million, and $15.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Hims & Hers Health 7.42 Bn 6.57 Bn 480.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -86.29 Mn
Mar 31, 2026 -92.12 Mn
Dec 31, 2025 20.60 Mn
Sep 30, 2025 15.77 Mn
Jun 30, 2025 42.51 Mn
Mar 31, 2025 49.49 Mn
Dec 31, 2024 26.03 Mn
Sep 30, 2024 75.59 Mn
Jun 30, 2024 13.30 Mn
Mar 31, 2024 11.13 Mn
Dec 31, 2023 1.25 Mn
Sep 30, 2023 -7.57 Mn
Jun 30, 2023 -7.16 Mn
Mar 31, 2023 -10.07 Mn
Dec 31, 2022 -10.91 Mn
Sep 30, 2022 -18.84 Mn
Jun 30, 2022 -19.68 Mn
Mar 31, 2022 -16.25 Mn
Dec 31, 2021 -31.16 Mn
Sep 30, 2021 -15.94 Mn